Evidence map›Paper›PMID 33898500›Full record

ReviewFrontiers in nutrition2021

Potential Applications of Endo-β-

Hatice Duman, Merve Kaplan, Ayşenur Arslan, Arif Sercan Sahutoglu, Haci Mehmet Kayili, Steven A Frese, Sercan Karav

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in nutrition, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 28 citations in OpenAlex.

  1. Trial
  2. Review
  3. Exploring the Activity of a NovelInternational journal of molecular sciences · 2025
    Article
  4. Proteomic andMicrobiology spectrum · 2025
    Article
  5. Osteopontin: Its Properties, Recent Studies, and Potential Applications.International journal of molecular sciences · 2025
    Review
  6. Novel Endo-β-Foods (Basel, Switzerland) · 2025
    Article
  7. Review
  8. Review
  9. Review
  10. Review
  11. Review
  12. Review
  13. Review
  14. Review
  15. Article
  16. Article
  17. Review
  18. Review
  19. Immobilization of a Bifidobacterial Endo-Frontiers in bioengineering and biotechnology · 2022
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Hatice DumanDepartment of Molecular Biology and Genetics, Çanakkale Onsekiz Mart University, Çanakkale, Turkey.
Merve KaplanDepartment of Molecular Biology and Genetics, Çanakkale Onsekiz Mart University, Çanakkale, Turkey.
Ayşenur ArslanDepartment of Molecular Biology and Genetics, Çanakkale Onsekiz Mart University, Çanakkale, Turkey.
Arif Sercan SahutogluDepartment of Chemistry, Çanakkale Onsekiz Mart University, Çanakkale, Turkey.
Haci Mehmet KayiliDepartment of Biomedical Engineering, Karabuk University, Karabük, Turkey.
Steven A FreseDepartment of Nutrition, University of Nevada, Reno, NV, United States.
Sercan KaravDepartment of Molecular Biology and Genetics, Çanakkale Onsekiz Mart University, Çanakkale, Turkey.
Çanakkale Onsekiz Mart Üniversitesi · TRKarabük University · TRUniversity of Nebraska–Lincoln · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Human milk is the optimal source of infant nutrition. Among many other health benefits, human milk can stimulate the development of a

Indexed as

bifidobacteriaendo-β-N-acetylglucosaminidasehuman milk oligosaccharidesinfant formulaN-glycans

Identifiers

PMID33898500
PMCPMC8063050
OpenAlexW3155202615

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.